Melbourne's Peter MacCallum Cancer Centre to be home of 'the next great wave in treatment'

25 March 2019 - A new form of cancer treatment that uses cell therapy to attack the disease will become ...

Read more →

Institute for Clinical and Economic Review releases draft evidence report on siponimod for treating secondary progressive multiple sclerosis

14 March 2019 - Public comment period now open until 10 April 2019; requests to make oral comment during public meeting ...

Read more →

One in four cancer patients wait two months for treatment, as NHS performance hits record low

14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...

Read more →

The Liberals’ plan for Pharmacare? We’re still waiting

14 March 2019 - The Trudeau government is edging closer to announcing its proposals for some kind of national drug ...

Read more →

Patient advocates applaud Cancer Drug Parity Act filed in both the U.S. House and Senate

13 March 2019 - The Coalition to Improve Access to Cancer Care and its members from across the cancer patient ...

Read more →

An EU wide approach to HTA: an irrelevant development or an opportunity not to be missed?

14 March 2019 - An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness ...

Read more →

European Commission approves Merck’s Keytruda (pembrolizumab) in combination with chemotherapy for first-line treatment of adults with metastatic squamous non-small cell lung cancer

14 March 2019 - European approval based on KEYNOTE-407 study results demonstrating significant improvement in overall survival with Keytruda in combination ...

Read more →

European Commission approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors

14 March 2019 - First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis, in a prospective intra-patient ...

Read more →

UK breast cancer patients win early access to Tecentriq/nab-paclitaxel

14 March 2019 - Adults in the UK with PD-L1 positive, unresectable locally advanced or metastatic triple-negative breast cancer have ...

Read more →

House Democrats investigate Trump backed short-term health plans

14 March 2019 - Energy & Commerce Chairman Pallone writes 12 insurance firms. ...

Read more →

Statement by FDA Commissioner on new strategies to modernise clinical trials to advance precision medicine, patient protections and more efficient product development

14 March 2019 - Modernizing clinical trials is an agency wide priority.  ...

Read more →

CMS updates drug dashboards with prescription drug pricing and spending data

14 March 2019 - Dashboards further the agency’s efforts to increase price transparency throughout the healthcare system and create incentives ...

Read more →

How Eli Lilly’s new generic insulin could impact prices across the market

14 March 2019 - The list price is $137.35 per vial. ...

Read more →

FDA grants Purdue Pharma’s nalmefene hydrochloride injection fast track designation for the emergency treatment of known or suspected opioid overdose

13 March 2019 - Committed to advancing solutions to the opioid public health crisis, Purdue will not profit from nalmefene hydrochloride. ...

Read more →

Cancer patient denied life-prolonging drug as she lives half a mile outside England

13 March 2019 - A seriously ill mum-of-two has spoken of her devastation after being denied a life prolonging cancer drug ...

Read more →

Pharma urges politicians to stop no-deal Brexit in today’s vote

13 March 2019 - Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that ...

Read more →